Todd Czerwinski joined the Micronoma team formally in May of 2022 as the Vice President of Business Development. Originally from the suburbs of Detroit, he has been in San Diego since the summer of 1995 (he wants us to know it was early September ’95 –...
Fungal DNA is present in various types of cancer, according to two studies published yesterday (September 29) in Cell. The findings add support to a hypothesized link between fungi and certain cancers, although researchers emphasize that there isn’t yet evidence for a...
Celia Sepulveda joined Micronoma formally in April of 2022 as the Corporate Communications Director, though she has been working with Micronoma as a consultant from the announced launch in fall of 2020. Born in Santa Rosa, California and raised in New Jersey, she has...
Andrew Lin joined Micronoma in July 2021 as a CLS Supervisor and is responsible for building, operating, and managing a clinical lab that is compliant with all CLIA/CAP/NY regulations. Though originally from Yorba Linda, Ca, he has lived in San Diego for the last four...
As we pave the way for better patient outcomes with the first minimally invasive microbiome-driven liquid biopsy technology, we also want to make sure that the important economic benefits that health insurance companies will reap from covering early cancer detection...
